MetaCap

Who Owns Alto Neuroscience Stock?

NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD

25.37-1.14 (-4.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
94.74%
Institutional holders
181
  • Institutions 94.7%
  • Insiders 4.3%
  • Public and other 1.0%

Who owns Alto Neuroscience stock?

Institutional investors own about 94.7% of Alto Neuroscience's shares, spread across 181 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.26% of ANRO.

The largest institutional holders are Alpha Wave Global, LP (9.24%), Blackrock Inc. (6.80%) and Commodore Capital Lp (6.79%). Together, the top 10 institutions control 47.5% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ANRO positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ANRO

Alto Neuroscience top institutional holders
InstitutionShares% HeldChange
Alpha Wave Global, LP3.71M9.24%0.0%
Blackrock Inc.2.73M6.80%+28.5%
Commodore Capital Lp2.72M6.79%0.0%
Vanguard Capital Management LLC1.69M4.22%+21.7%
Spruce Street Capital LP1.68M4.18%+23.9%
Perceptive Advisors Llc1.61M4.01%-19.9%
Adage Capital Partners GP L.L.C.1.60M3.99%+315.6%
Vivo Capital, LLC1.36M3.39%+12.5%
Franklin Templeton, Inc.993.49K2.48%-2.0%
State Street Corporation946.04K2.36%+37.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ANRO

Alto Neuroscience top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.01M2.52%
iShares Trust-iShares Russell 2000 ETF836.52K2.09%
Franklin Strategic Series-Franklin Biotechnology Discovery Fund347.90K0.87%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund346.62K0.86%
iShares Trust-iShares Russell 2000 Growth ETF298.27K0.74%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund287.03K0.72%
iShares Trust-iShares Biotechnology ETF279.35K0.70%
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF251.09K0.63%
T. Rowe Price Health Sciences Fund, Inc.228.06K0.57%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund179.26K0.45%

Frequently asked questions

Who is the largest shareholder of Alto Neuroscience?

Alpha Wave Global, LP is the largest institutional shareholder of ANRO, owning 9.24% of shares outstanding (3.71M shares) as of its latest 13F filing.

What percentage of Alto Neuroscience is owned by institutions?

Institutions own about 94.7% of ANRO shares and 99.0% of the public float.

How much of Alto Neuroscience do insiders own?

Insiders, such as officers and directors, own about 4.26% of ANRO shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related